Injuries Reported with the Triumph TF250-X Off-Road Motorcycle
The Triumph TF250-X Off-Road Motorcycle, which is imported by Triumph Motorcycles America, has been recalled because it has a flaw that can result in injuries. Specifically, the plastic switch cube on the right side of the motorcycle may crack if it comes into contact with brake fluid; this in turn may result in a short circuit that unexpectedly starts the motorcycle. Riders or other people can be injured. The recall was issued on February 20, 2025.
Call the Chicago-Based Trial Lawyers of Moll Law Group
The products at issue are the black 2024 and 2025 Triumph TF250-X Closed Competition Motorcycle, which have vehicle identification numbers (VIN) between BP6028 and CC7868 specified on the left side of the motorcycle’s steering head. Around 690 units are affected, and you can see whether your VIN is included in the recall by going to https://www.triumphmotorcycles.com/owners/recalls.
These off-road motorcycles, made in Thailand, were sold from July 2023-December 2024. The cost was roughly $9500.
Illinois Injury and Mass Tort Lawyer Blog





Recently, after a three-week trial, jurors in a state court
Recently, ICU Medical, Inc.
4, the Chicago-based company Riverside Natural Foods
A multistate outbreak of listeria monocytogenes has impacted frozen supplement shakes made by Prairie Farms. As of February 21, 2025, 38 people have been infected by the outbreak across 21 states. On February 22, 2025, Lyons Magnus LLC
Semaglutide in the form of drugs like Ozempic, Mounjaro, Wegovy, Rybelsus and Zepbound may increase the risks of vision loss. These drugs are taken to manage type 2 diabetes and obesity and have the potential to help other medical problems like depression, addiction, and Alzheimer’s. Unfortunately, it also appears that one of the drugs’ potential side effects is a rare kind of vision loss, non-arteritic anterior ischemic optic neuropathy (
In February, the Food and Drug Administration (FDA) announced that it is
Red No. 3 is used as bright red artificial coloring in candy, cereal, fruit cocktails, strawberry-flavored milkshakes, and other foods and beverages. It’s ubiquitous. And so it’s alarming that data has surfaced that the dye can cause cancer in lab animals; specifically, evidence reveals that lab male rats exposed to heightened
2025 opened with announcements from the U.S. Food and Drug Administration (FDA) about cessation of smoking and the reduction of nicotine addiction. The first of the two announcements was a Notice of Proposed Rulemaking. This would call for a reduction in nicotine in combustible tobacco products to levels that are not addictive. This has been requested by public health advocates since 2009’s Family Smoking Prevention and Tobacco Control Act, which authorized such a change. The agency has set out a comment period that from January 16 all the way to September 15 of this year. However, the other announcement had to do with authorizing 3 mg and 6 mg nicotine content in a
In an important legal step, the Depo-Provera birth control lawsuits have been centralized and transferred to